Wacker Chemie AG CMD Series: Biosolutions & R&D Transcript
Welcome, everybody, to the Wacker Chemie AG Virtual Capital Market Day on R&D and BioSolutions. Before we begin, please allow me to point you to safe harbor statement, which you'll find at the slide deck's beginning. You will also find a slido.com link there that enables you to ask questions during the Q&A session at the end of today's presentation.
Today's presenters are Chris Hartel, our CEO; Tobias Ohler, our CFO; Susanne Leonhartsberger, President of BioSolutions; and Christoph Kowitz, Head of R&D. The presentation is available to download on our web page under the caption Investor Relations. Chris?
Thank you, Joerg. Ladies and gentlemen, welcome to the third edition of our Virtual Capital Market Day series. In June and December of last year, we first covered a strategy update and our main chemical segments. Today, we will speak about key growth progress beyond silicones and polymers. Our next edition in Q4
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |